194 related articles for article (PubMed ID: 8945674)
21. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
[TBL] [Abstract][Full Text] [Related]
22. IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.
Chen J; Komori S; Li B; Tamura K; Hashimoto K
Br J Pharmacol; 1996 Nov; 119(5):937-42. PubMed ID: 8922743
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.
Lengyel C; Iost N; Virág L; Varró A; Lathrop DA; Papp JG
Br J Pharmacol; 2001 Jan; 132(1):101-10. PubMed ID: 11156566
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of MS-551 and E-4031 on action potentials and the delayed rectifier K+ current in rabbit ventricular myocytes.
Cheng J; Kamiya K; Kodama I; Toyama J
Cardiovasc Res; 1996 Jun; 31(6):963-74. PubMed ID: 8759253
[TBL] [Abstract][Full Text] [Related]
25. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle.
Tsuji Y; Opthof T; Kamiya K; Yasui K; Liu W; Lu Z; Kodama I
Cardiovasc Res; 2000 Nov; 48(2):300-9. PubMed ID: 11054476
[TBL] [Abstract][Full Text] [Related]
26. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
Amos GJ; Abrahamsson C; Duker G; Hondeghem L; Palmer M; Carlsson L
Cardiovasc Res; 2001 Feb; 49(2):351-60. PubMed ID: 11164845
[TBL] [Abstract][Full Text] [Related]
27. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.
Jurkiewicz NK; Sanguinetti MC
Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848
[TBL] [Abstract][Full Text] [Related]
28. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
Yao JA; Tseng GN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
[TBL] [Abstract][Full Text] [Related]
29. The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes.
Liu XK; Katchman A; Ebert SN; Woosley RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):877-83. PubMed ID: 9864267
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
[TBL] [Abstract][Full Text] [Related]
31. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.
Drolet B; Khalifa M; Daleau P; Hamelin BA; Turgeon J
Circulation; 1998 Jan; 97(2):204-10. PubMed ID: 9445174
[TBL] [Abstract][Full Text] [Related]
32. Density and kinetics of I(Kr) and I(Ks) in guinea pig and rabbit ventricular myocytes explain different efficacy of I(Ks) blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans.
Lu Z; Kamiya K; Opthof T; Yasui K; Kodama I
Circulation; 2001 Aug; 104(8):951-6. PubMed ID: 11514385
[TBL] [Abstract][Full Text] [Related]
33. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM
Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of the delayed rectifier K current compared in myocytes isolated from the atrioventricular node and ventricle of the rabbit heart.
Howarth FC; Levi AJ; Hancox JC
Pflugers Arch; 1996 Mar; 431(5):713-22. PubMed ID: 8596721
[TBL] [Abstract][Full Text] [Related]
35. The new antiarrhythmic substance AWD 23-111 inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.
Klapperstück M; Markwardt F
Pharmazie; 1999 Jan; 54(1):61-8. PubMed ID: 9987799
[TBL] [Abstract][Full Text] [Related]
36. Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes.
de Lorenzi FG; Bridal TR; Spinelli W
Br J Pharmacol; 1994 Oct; 113(2):527-35. PubMed ID: 7834204
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide.
Hanada E; Ohtani H; Hirota M; Uemura N; Nakaya H; Kotaki H; Sato H; Yamada Y; Iga T
J Pharm Pharmacol; 2003 Jul; 55(7):995-1002. PubMed ID: 12906757
[TBL] [Abstract][Full Text] [Related]
39. Rate dependent effects of procainamide on the threshold current for pacing in the setting of postrepolarization refractoriness in dogs.
Leerssen HM; Vos MA; den Dulk K; van der Zande J; Wellens HJ
Pacing Clin Electrophysiol; 1999 Feb; 22(2):291-301. PubMed ID: 10087543
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell.
Liu DW; Antzelevitch C
Circ Res; 1995 Mar; 76(3):351-65. PubMed ID: 7859382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
